Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine

Vaccine

Volumn 29, Issue 25, 2011, Pages 4238-4243

  Anhang Price, Rebecca ^a   Koshiol, Jill ^b   Kobrin, Sarah ^b   Tiro, Jasmin A ^c  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cancer screening; Cervical cancer; Disparities; Human papillomavirus (HPV)

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT PARTICIPATION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION;

ADOLESCENT; ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 79956205908     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.076     Document Type: Article

References (38)

1. Medeiros L.R., Rosa D.D., da Rosa M.I., Bozzetti M.C., Zanini R.R. Efficacy of human papillomavirus vaccines: a systematic quantitative review. Int J Gynecol Cancer 2009, 19(October (7)):1166-1176.
2. Munoz N., Kjaer S.K., Sigurdsson K., Iversen O.E., Hernandez-Avila M., Wheeler C.M., et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010, 102(March (5)):325-339.
3. Romanowski B., de Borba P.C., Naud P.S., Roteli-Martins C.M., De Carvalho N.S., Teixeira J.C., et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009, 374(December (9706)):1975-1985.
4. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007, 57(January-February (1)):7-28.
5. Tiro J.A., Saraiya M., Jain N., Liddon N., Cokkinides V., Lai S.M., et al. Human papillomavirus and cervical cancer behavioral surveillance in the US. Cancer 2008, 113(November (10 Suppl.)):3013-3030.
6. Centers for Disease Control and Prevention (CDC) Behavioral risk factor surveillance system survey data 2004, U.S. Department of Health and Human Services, Atlanta (GA).
7. National Council on Quality Assurance The state of health care quality 2006, National Council on Quality Assurance, Washington (DC).
8. Hewitt M., Devesa S.S., Breen N. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med 2004, 39(August (2)):270-278.
9. Ayanian J.Z., Weissman J.S., Schneider E.C., Ginsburg J.A., Zaslavsky A.M. Unmet health needs of uninsured adults in the United States. JAMA 2000, 284(October (16)):2061-2069.
10. Hsia J., Kemper E., Kiefe C., Zapka J., Sofaer S., Pettinger M., et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000, 31(September (3)):261-270.
11. Mandelblatt J.S., Gold K., O'Malley A.S., Taylor K., Cagney K., Hopkins J.S., et al. Breast and cervix cancer screening among multiethnic women: role of age, health, and source of care. Prev Med 1999, 28(April (4)):418-425.
12. Robinson J.M., Shavers V. The role of health insurance coverage in cancer screening utilization. J Health Care Poor Underserved 2008, 19(August (3)):842-856.
13. Swan J., Breen N., Coates R.J., Rimer B.K., Lee N.C. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003, 97(March (6)):1528-1540.
14. Freeman H.P., Wingrove B.K. Excess cervical cancer mortality: a marker for low access to health care in poor communities May 2005, National Cancer Institute Center to Reduce Cancer Health Disparities, Rockville (MD).
15. Watson M., Saraiya M., Benard V., Coughlin S.S., Flowers L., Cokkinides V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008, 113(November (10 Suppl.)):2855-2864.
16. Tiro J.A., Meissner H.I., Kobrin S., Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol Biomarkers Prev 2007, 16(February (2)):288-294.
17. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45(November (5)):453-462.
18. Chao C., Slezak J.M., Coleman K.J., Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99(June (6)):1137-1142.
19. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171(February (3)):357-367.
20. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009, 48(May (5)):426-431.
21. The American Association for Public Opinion Research Standard definitions: final dispositions of case codes and outcome rates for surveys 2008, AAPOR, Lenexa, KS. 5th ed.
22. National Center for Health Statistics 2008 National Health Interview Survey (NHIS) public use data release: NHIS Survey Description 2009, [accessed 08.06.2010]. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2008/srvydesc.pdf.
23. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(March (RR-2)):1-24.
24. Saslow D., Runowicz C.D., Solomon D., Moscicki A.B., Smith R.A., Eyre H.J., et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002, 52(November-December (6)):342-362.
25. U.S.Preventive Services Task Force Guide to clinical preventive services 2003, U.S. Department of Health and Human Services, Washington (DC). 3rd ed.
26. ACOG Practice Bulletin No. 109: cervical cytology screening. Obstet Gynecol 2009, 114(December (6)):1409-1420.
27. Hiatt R.A., Klabunde C., Breen N., Swan J., Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst 2002, 94(December (24)):1837-1846.
28. Anhang Price R, Tiro J, Saraiya M, Meissner H, Breen N., Use of human papillomavirus vaccines among young adult women in the United States: an analysis of the 2008 National Health Interview Survey Cancer, In press, 2011.
29. Conroy K., Rosenthal S.L., Zimet G.D., Jin Y., Bernstein D.I., Glynn S., et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009, 18(October (10)):1679-1686.
30. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(August (32)):1018-1023.
31. Scarinci I.C., Garcia F.A., Kobetz E., Partridge E.E., Brandt H.M., Bell M.C., et al. Cervical cancer prevention: new tools and old barriers. Cancer 2010, 116(June (11)):2531-2542.
32. Kim J.J., Goldie S.J. Health and economic implications of HPV vaccination in the United States. N Engl J Med 2008, 359(August (8)):821-832.
33. Sirovich B.E., Welch H.G. The frequency of Pap smear screening in the United States. J Gen Intern Med Mar 2004, 19(3):243-250.
34. Saraiya M., Martinez G., Glaser K., Kulasingam S. Pap testing and sexual activity among young women in the United States. Obstet Gynecol 2009, 114(December (6)):1213-1219.
35. Meissner H.I., Tiro J.A., Yabroff K.R., Haggstrom D.A., Coughlin S.S. Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals. Med Care 2010, 48(March (3)):249-259.
36. Schwartz L.M., Woloshin S., Fowler F.J., Welch H.G. Enthusiasm for cancer screening in the United States. JAMA 2004, 291(January (1)):71-78.
37. Yabroff K.R., Saraiya M., Meissner H.I., et al. Specialty differences in primary care physician reports of papanicolaou test screening practices: a national survey, 2006 to 2007. Ann Intern Med 2009 Nov 3, 151(9):602-611.
38. Blumberg S.J., Luke J.V. Coverage bias in traditional telephone surveys of low-income and young adults. Public Opin Quart 2007, 71(5):734-749.